In this paper, we present a continuation of the evaluation of MMPs as new tumor markers for breast cancer, this time by assessing two metalloproteinases MMP-3 and MMP-7 as a diagnostic marker of early-stages breast cancer with Luminal A or Luminal B HER-negative subtypes. This evidence concerns the gene MMP3 and breast carcinoma.